论文部分内容阅读
冠脉内血栓形成是急性心肌梗塞(AMI)的主要原因,溶栓治疗是近年的重要进展。1991年10月～1994年10月共收治AMI 41例,其中15例用尿激酶(UK)静脉溶栓治疗。本文比较两者住院期间并发症发生率和病死率,以及溶栓治疗对血小板活化的影响。
Coronary thrombosis is the main cause of acute myocardial infarction (AMI). Thrombolytic therapy is an important advance in recent years. From October 1991 to October 1994, 41 patients were treated with AMI, of which 15 were treated with intravenous thrombolytic therapy with urokinase (UK). This article compares the two during hospitalization complications and mortality, and thrombolytic therapy on platelet activation.